JPRN-jRCT2080221229未知1 期
A phase 1/2 study of E6005 in Japanese patients with atopic dermatitis
适应症
试验速览
- 阶段
- 1 期
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 65age old（—）
- 性别
- Male
入选标准
- •Japanese adult male patients with a confirmed diagnosis of atopic dermatitis according to Guidelines for Management of Atopic Dermatitis by the Japanese Dermatological Association.
排除标准
- •-Patients complicated with eye symptoms (e.g., cataract, retinal detachment), Kaposi varicelliform eruption, and molluscum contagiosum or impetigo contagiosa.
- •-Patients who had or have a severe allergy such as anaphylactic shock, anaphylactic reaction and anaphylactoid reaction or allergy/hypersensitivity to E6005 or any of their excipients.
研究者
相似试验
终止
2 期
A Clinical Phase 2 Study of E6011 in Japanese Subjects with Primary Biliary Cholangitis Inadequately Responding to Ursodeoxycholic AcidPrimary Biliary CholangitisJPRN-jRCT2080223460EA Pharma Co.,Ltd.80
已完成
2 期
Japanese phase II study in untreated patients with CD20 positive B-cell non-Hodgkin's lymphoma evaluating safety of 90-minute infusion of rituximab.CD20 positive follicular lymphoma or diffuse large B-cell lymphoma.JPRN-jRCT2080223607ZENYAKU KOGYO CO., LTD.33
未知
1 期
A Phase 1 Study of LY2606368 in Japanese Patients with Advanced Solid TumorseoplasmJPRN-jRCT2080222962Eli Lilly Japan K.K.
未知
1 期
A phase 1, single-dose study of E6011 in Japanese healthy adult subjectsJPRN-jRCT2080221973Eisai Co., Ltd.64
未知
2 期
Phase II Study of S-555739 in Patients with Japanese Cedar Pollinosis in an Environmental Challenge ChamberJPRN-jRCT2080221936SHIONOGI & CO., LTD.